Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaotongti analgesic plaster (also known as Xiaotong Tie Gao) is a Traditional Chinese Medicine (TCM) topical patch primarily developed and manufactured by Tibet Cheezheng Tibetan Medicine. It is formulated with a blend of herbal extracts, including *Herba Meconopsis* (Tibetan poppy), *Radix et Rhizoma Rhei* (Rhubarb), and *Cortex Zanthoxyli* (Prickly ash), which are traditionally used to promote blood circulation, resolve blood stasis, and alleviate pain and swelling. The plaster is widely used in China for the treatment of musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, chronic back pain, and soft tissue injuries. In clinical settings, it has been evaluated for its efficacy in treating refractory plantar fasciitis, often in combination with other therapies like extracorporeal shock wave therapy (ESWT) or nerve blocks. Its mechanism of action involves the inhibition of inflammatory mediators such as cyclooxygenase-2 (COX-2) and various pro-inflammatory cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaotongti analgesic plaster.